H-Orn(pyrazinylcarbonyl)-OH

H-Orn(pyrazinylcarbonyl)-OH is a protected-free ornithine-derived amino acid derivative bearing an N-(pyrazinylcarbonyl) amide on the side-chain and a free carboxylic acid at the α-position, providing a chiral amino acid framework suitable for peptide and medicinal chemistry workflows. The molecule features an ornithine backbone with a stereogenic center at the α-carbon, while the side-chain terminus is converted into a carboxamide that incorporates a pyrazine ring, introducing a heteroaromatic functionality with defined hydrogen-bonding and aromatic nitrogen acceptor sites. The presence of an unprotected α-carboxylic acid and a primary amide restricts uncontrolled polymerization while enabling controlled coupling chemistry and downstream derivatization through standard amino acid activation strategies. The pyrazinylcarbonyl motif can participate in heteroaromatic recognition and can serve as a stable handle for constructing peptidomimetics, assembling constrained analogs, and preparing biochemical research intermediates where heteroaromatic substitution patterns matter.

1. Peptide Synthesis

H-Orn(pyrazinylcarbonyl)-OH supports peptide coupling chemistry in synthetic peptide workflows by presenting an α-carboxylic acid for activation and an amide-bearing side chain that remains compatible with common coupling conditions. The ornithine-derived side chain, capped as a pyrazinylcarbonyl amide, maintains a defined functional topology for stepwise chain assembly and can be used to generate peptide building blocks with heteroaromatic side-chain recognition elements. The stereochemical integrity at the α-center enables incorporation into defined chiral sequences for peptide analog construction and structure-activity relationship studies. Downstream, the resulting peptide fragments can be further functionalized at other positions while preserving the pyrazine-containing pharmacophore-like moiety for binding studies and scaffold diversification.

2. Peptidomimetics And SAR Studies

H-Orn(pyrazinylcarbonyl)-OH is suitable for peptidomimetic construction and SAR studies because the pyrazinylcarbonyl side-chain introduces a heteroaromatic group that can mimic polar interactions within peptide-like scaffolds. The combination of an ornithine backbone and a side-chain amide provides a rigid, directionally informative linkage that can influence conformational preferences and intermolecular hydrogen-bonding patterns. The free α-carboxylic acid enables conversion into activated intermediates for incorporation into constrained analogs, while the amide and pyrazine ring support further derivatization such as N-alkylation or heteroaromatic substitution planning in medicinal chemistry routes. The stereodefined amino acid framework supports systematic SAR mapping where side-chain electronics and hydrogen-bond acceptor placement are tuned across analog series.

3. Chemical Biology Probes

H-Orn(pyrazinylcarbonyl)-OH can be applied in chemical biology research as a heteroaromatic amino acid intermediate for probe design and biomolecular interaction studies. The pyrazine ring provides multiple nitrogen acceptors that can participate in noncovalent recognition, enabling incorporation into labeled peptides, affinity tags, or binding-site mimics used to interrogate molecular interactions. The α-carboxylic acid supports conjugation planning through standard coupling handles, while the side-chain amide stabilizes the heteroaromatic motif against harsh conditions that may be used during probe assembly. The resulting constructs can serve as research intermediates for studying binding specificity, competitive recognition, and structure-dependent interaction patterns in biochemical assay development.

4. Heterocycle-Functionalized Building Blocks

H-Orn(pyrazinylcarbonyl)-OH functions as a heterocycle-functionalized amino acid building block for synthetic organic chemistry routes that require a pyrazine-containing motif embedded in a chiral amino acid scaffold. The pyrazinylcarbonyl group offers a chemically stable heteroaromatic unit that can be carried through peptide coupling steps and later used as a platform for further heteroaromatic chemistry, including substitution and electronic tuning strategies. The ornithine-derived side-chain amide provides a defined acyl linkage that can be retained during intermediate transformations, supporting multi-step synthesis where orthogonal reactivity is needed. Downstream utility includes preparation of chiral intermediates for combinatorial library synthesis and fine chemical production where heteroaromatic incorporation into amino acid-derived frameworks is required.

5. Process Chemistry Intermediate

H-Orn(pyrazinylcarbonyl)-OH is applicable as a process chemistry intermediate for manufacturing routes that require chiral amino acid derivatives bearing a stable heteroaromatic amide functionality. The molecule's functional group set, consisting of a free α-carboxylic acid and an N-acylated side chain, supports controlled conversion into activated derivatives for peptide building block preparation and enables downstream coupling steps in a reproducible manner. The pyrazine-containing amide can withstand common protection/deprotection logic used in amino acid synthesis, allowing it to be carried through sequence assembly or intermediate purification stages without losing the heteroaromatic handle. Industrially relevant downstream formation includes generation of amino acid-derived coupling partners, peptidomimetic fragments, and specialty chemical intermediates where stereodefined ornithine chemistry and heteroaromatic incorporation are required for consistent batch-to-batch scaffold construction.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. High fat diet and GLP-1 drugs induce pancreatic injury in mice

3. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients